drugset / Trial / NCT07301203
Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
RandomizedSequentialQuadruple-blindPrevention
Summary
This is a Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of CPD704 inhalation suspension in healthy Chinese adult subjects.
Timeline
- Start
- 2025-10-21
- Primary completion
- 2026-06-08
- Completion
- 2026-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CPD704 | Unknown | 0.5 mg | Inhaled |
| Subject | CPD704 | Unknown | 1.5 mg | Inhaled |
| Subject | CPD704 | Unknown | 3 mg | Inhaled |
| Subject | CPD704 | Unknown | 6 mg | Inhaled |
| Subject | CPD704 | Unknown | 9 mg | Inhaled |
| Subject | CPD704 | Unknown | 12 mg | Inhaled |
Indications
No indication recorded.